Torthaí cuardaigh - Jonathan P. DiNitto

  • 1 - 5 toradh as 5 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Structural determinants of phosphoinositide selectivity in splice variants of Grp1 family PH domains

    Structural determinants of phosphoinositide selectivity in splice variants of Grp1 family PH domains de réir Thomas C. Cronin, Jonathan P. DiNitto, Michael Czech, David G. Lambright

    Foilsithe / Cruthaithe 2004
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Structural Basis and Mechanism of Autoregulation in 3-Phosphoinositide-Dependent Grp1 Family Arf GTPase Exchange Factors

    Structural Basis and Mechanism of Autoregulation in 3-Phosphoinositide-Dependent Grp1 Family Arf GTPase Exchange Factors de réir Jonathan P. DiNitto, Anna Delprato, Meng‐Tse Gabe Lee, Thomas C. Cronin, Shao Hui Huang, Adı́lson Guilherme, Michael Czech, David G. Lambright

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients

    KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients de réir K.S. Gajiwala, Joe C. Wu, James G. Christensen, Gayatri D. Deshmukh, Wade Diehl, Jonathan P. DiNitto, Jessie M. English, Michael J. Greig, You-Ai He, Suzanne L. Jacques, Elizabeth A. Lunney, Michele McTigue, David A. Castillo Molina, Terri Quenzer, Peter A. Wells, Xiu Yu, Yan Zhang, Aihua Zou, Mark R. Emmett, Alan G. Marshall, Hui‐Min Zhang, George D. Demetri

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate

    Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ Inhibitor (IPI-549) as an Immuno-Oncology Clinical Candidate de réir Catherine A. Evans, Tao Liu, André Lescarbeau, Somarajan Nair, Louis Grenier, Johan A. Pradeilles, Quentin Glenadel, Thomas T. Tibbitts, Ann Rowley, Jonathan P. DiNitto, Erin Brophy, Erin O’Hearn, Janid A. Ali, David G. Winkler, Stanley I. Goldstein, Patrick J. O’Hearn, Christian M. Martin, Jennifer Hoyt, John R. Soglia, Culver Cheung, Melissa Pink, Jennifer Proctor, Vito J. Palombella, Martin Tremblay, Alfredo Castro

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models

    PI3K-δ and PI3K-γ Inhibition by IPI-145 Abrogates Immune Responses and Suppresses Activity in Autoimmune and Inflammatory Disease Models de réir David G. Winkler, L. Kerrie, Jonathan P. DiNitto, Janid A. Ali, Kerry White, Erin Brophy, Melissa Pink, Jennifer Proctor, Jennifer Lussier, Christian M. Martin, Jennifer Hoyt, Bonnie Tillotson, Erin L. Murphy, Alice R. Lim, Brian D. Thomas, John R. MacDougall, Pingda Ren, Yi Liu, Lian‐Sheng Li, Katti Jessen, Christian Fritz, Joi Dunbar, James R. Porter, Christian Rommel, Vito J. Palombella, Paul S. Changelian, Jeffery L. Kutok

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: